Corvus Pharmaceuticals

+$0.0329 (+3.40%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRVS and other ETFs, options, and stocks.

About CRVS

Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor.

CEO
Richard A. Miller
Employees
28
Headquarters
Burlingame, California
Founded
2014

CRVS Key Statistics

Market cap
46.55M
Price-Earnings ratio
—
Dividend yield
—
Average volume
239.61K
High today
$1.01
Low today
$0.94
Open price
$0.96
Volume
117.15K
52 Week high
$9.54
52 Week low
$0.94

CRVS Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure